Area 2

Genetics and urologic tumors

Articles during the year 2015

Published originals: 12

Impact factor: mean: 2.8, total: 33.55

  • Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications

    van Rhijn BW, Musquera M, Liu L, Vis AN, Zuiverloon TC, Van Leenders GJ, Kirkels WJ, Zwarthoff EC, Boevé ER, Jobsis AC, Bapat B, Jewett MA, Zlotta AR, van der Kwast TH
    Mod Pathol. 2015; 28(5): 695-705. IF: 6.187

  • Coagulation profiles of unexpected DCDD donors do not indicate a role for exogenous fibrinolysis

    Vendrell M, Hessheimer AJ, Ruiz A, de Sousa E, Paredes D, Rodríguez C, Saavedra S, Fuster J, Alcaraz A, Oppenheimer F, Taurá P, García-Valdecasas JC, Fondevila C
    Am J Transplant. 2015; 15(3): 764-771. IF: 5.683

  • The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy

    Morote J, Gómez A, Alvarez-Ossorio JL, Pesqueira D, Tabernero A, Gomez Veiga F, Lorente JA, Porras M, Lobato JJ, Ribal MJ, Planas J; ANAMET investigators group
    J Urol. 2015; 193(6): 1963-1969. IF: 4.360

  • The role of cystectomy in elderly patients – a multicentre analysis

    Izquierdo L, Peri Ll, Leon P, Ramirez-Backhaus M, Manning T, Alcaraz A, Roupret M, Solsona E, Rubio P, Sengupta S, Chan Y, Liodakis P, Gyomber D, Bolton D, Lawrentschuk N
    BJU Int. 2015; 116(3): 73-79. IF: 3.533

  • Current patterns of management of advanced prostate câncer in routine clinical practice in Spain

    Ribal MJ, Martínez-Salamanca Jl, García Freire C
    Prostate Cancer. 2015; 186740: 0-0. IF: 3.425


Published editorials: 1

Impact factor: mean: 3.53, total: 3.53

  • Controversies in management of high-risk prostate and bladder cancer

    Loeb S, Ribal MJ
    BJU Int. 2015; 116(5): 675-0. IF: 3.533

More articles